Jazz Pharmaceuticals (JAZZ) Current Deferred Tax Assets (2012 - 2015)

Jazz Pharmaceuticals (JAZZ) posted quarterly Current Deferred Tax Assets of $50.0 million for Q3 2015, up 40.09% year-over-year from $35.7 million in Q3 2014, and down 1.18% quarter-over-quarter from $50.6 million in Q2 2015.

Jazz Pharmaceuticals (JAZZ) Current Deferred Tax Assets (2012 - 2015) Analysis & Trends

Jazz Pharmaceuticals' Current Deferred Tax Assets history runs 4 years deep, the most recent figure standing at $50.0 million for Q3 2015.

  • In Q3 2015, Current Deferred Tax Assets rose 40.09% year-over-year to $50.0 million; the TTM figure through Sep 2015 stood at $50.0 million (up 40.09% YoY), while the FY2014 annual figure was $48.4 million, up 44.11% from the prior year.
  • Current Deferred Tax Assets for Q3 2015 stood at $50.0 million, down from $50.6 million in the prior quarter.
  • The five-year high for Current Deferred Tax Assets was $50.8 million in Q1 2015, with the low at $33.6 million in Q4 2013.
  • The 4-year median for Current Deferred Tax Assets is $46.1 million (2013), against an average of $43.0 million.
  • Peak annual rise in Current Deferred Tax Assets reached 44.11% in 2014, while the deepest fall reached 24.47% in 2014.
  • Jazz Pharmaceuticals' Current Deferred Tax Assets stood at $35.8 million in 2012, then slipped by 6.14% to $33.6 million in 2013, then surged by 44.11% to $48.4 million in 2014, then climbed by 3.23% to $50.0 million in 2015.
  • Business Quant data shows JAZZ's Current Deferred Tax Assets at $50.0 million in Q3 2015, $50.6 million in Q2 2015, and $50.8 million in Q1 2015.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Jazz Pharmaceuticals 15.90 Bn 14.28 Bn 1.09 Bn

Historic Data

Download Data
DateValue
Sep 30, 2015 50.01 Mn
Sep 30, 2015 50.01 Mn
Jun 30, 2015 50.60 Mn
Jun 30, 2015 50.60 Mn
Mar 31, 2015 50.82 Mn
Mar 31, 2015 50.82 Mn
Dec 31, 2014 48.44 Mn
Dec 31, 2014 48.44 Mn
Sep 30, 2014 35.70 Mn
Sep 30, 2014 35.70 Mn
Jun 30, 2014 35.87 Mn
Jun 30, 2014 35.87 Mn
Mar 31, 2014 35.89 Mn
Mar 31, 2014 35.89 Mn
Dec 31, 2013 33.61 Mn
Dec 31, 2013 33.61 Mn
Sep 30, 2013 45.57 Mn
Sep 30, 2013 45.57 Mn
Jun 30, 2013 46.54 Mn
Jun 30, 2013 46.54 Mn